RWTH

Accent Therapeutics Bolsters Leadership Team with Key Executive Hires

Retrieved on: 
Thursday, September 21, 2023

LEXINGTON, Mass., Sept. 21, 2023 /PRNewswire/ -- Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced the appointments of Jason Sager, M.D., as Chief Medical Officer, Steven Mennen, Ph.D., as Vice President of Pre-Clinical Development and Stuart Ince, Ph.D. as Vice President of Program Leadership.

Key Points: 
  • "Our dedication to fortifying our team underscores the remarkable progress we've achieved as Accent advances its lead programs towards the clinic," said Shakti Narayan, Chief Executive Officer of Accent.
  • Together, Jason, Steven, and Stuart's combined experience will be immensely valuable as Accent moves towards becoming a clinical-stage company and bringing novel therapies to patients."
  • These key executive hires enhance Accent's positioning to potentially advance two investigational programs into the clinic.
  • Accent is also on track to begin IND-enabling studies for a second undisclosed program by the end of 2023.

EnChroma Supports Colourblind Students at RWTH Aachen University

Retrieved on: 
Tuesday, November 22, 2022

VORSCHUB at RWTH Aachen University today announced that colourblind students and staff will now be able to borrow EnChroma colourblind glasses on campus to help them overcome the obstacles to learning and everyday life that colour vision deficiency (CVD) poses.

Key Points: 
  • VORSCHUB at RWTH Aachen University today announced that colourblind students and staff will now be able to borrow EnChroma colourblind glasses on campus to help them overcome the obstacles to learning and everyday life that colour vision deficiency (CVD) poses.
  • With over 47,000 students, and nearly 10,000 faculty and staff, an estimated 2,400 people at RWTH Aachen University are color blind.
  • VORSCHUB at RWTH Aachen University joins the University of Hamburg as the first European universities to align with numerous prestigious universities in the US in supporting the needs of colour blind students via the EnChroma Colour Accessibility Programme .
  • This Program is already helping colour blind students at Boston University, North Carolina State University, Penn State University, Alfred University and others.

Grünenthal, Uniklinik RWTH Aachen and RTWH Aachen University collaborate to advance pain research

Retrieved on: 
Thursday, July 7, 2022

AACHEN, Germany, July 7, 2022 /PRNewswire/ -- Grnenthal, Uniklinik RWTH Aachen and RWTH Aachen University announced a collaboration to advance the development of next-generation pain medicines.

Key Points: 
  • AACHEN, Germany, July 7, 2022 /PRNewswire/ -- Grnenthal, Uniklinik RWTH Aachen and RWTH Aachen University announced a collaboration to advance the development of next-generation pain medicines.
  • The collaboration involves the institutes of Dr Angelika Lampert, Professor of Physiology at the Uniklinik RWTH Aachen and Dr Marc Spehr, Lichtenberg-Professor for Chemosensation at the RWTH Aachen University.
  • The exploratory efforts at the Uniklinik RWTH Aachen and RWTH Aachen University will, if successful, enable their subsequent integration into drug development activities at Grnenthal.
  • The Uniklinik RWTH Aachen is a supramaximal care provider that combines patient-oriented medicine and nursing, teaching and research at an international level.

Grünenthal, Uniklinik RWTH Aachen and RTWH Aachen University collaborate to advance pain research

Retrieved on: 
Thursday, July 7, 2022

AACHEN, Germany, July 7, 2022 /PRNewswire/ -- Grnenthal, Uniklinik RWTH Aachen and RWTH Aachen University announced a collaboration to advance the development of next-generation pain medicines.

Key Points: 
  • AACHEN, Germany, July 7, 2022 /PRNewswire/ -- Grnenthal, Uniklinik RWTH Aachen and RWTH Aachen University announced a collaboration to advance the development of next-generation pain medicines.
  • The collaboration involves the institutes of Dr Angelika Lampert, Professor of Physiology at the Uniklinik RWTH Aachen and Dr Marc Spehr, Lichtenberg-Professor for Chemosensation at the RWTH Aachen University.
  • The exploratory efforts at the Uniklinik RWTH Aachen and RWTH Aachen University will, if successful, enable their subsequent integration into drug development activities at Grnenthal.
  • The Uniklinik RWTH Aachen is a supramaximal care provider that combines patient-oriented medicine and nursing, teaching and research at an international level.

crop.zone Secures USD 11 Million Equity Funding

Retrieved on: 
Tuesday, June 7, 2022

Nufarm Limited ) and new financial investors ( Demeter Investment Managers , Madaus Capital Partners ) have increased the equity base of the Aachen-based company by almost 11 million USD.

Key Points: 
  • Nufarm Limited ) and new financial investors ( Demeter Investment Managers , Madaus Capital Partners ) have increased the equity base of the Aachen-based company by almost 11 million USD.
  • The innovative crop.zone system offers a natural organic alternative to non-selective synthetic herbicides such as Glyphosate or Diquat.
  • As a highly productive and efficient solution, it is also used in desiccation applications and seedbed preparation.
  • crop.zone's and investors' objectives for the USD 11 million investment are to open up new international markets and to develop additional agronomic treatment patterns for the crop.zone system.

NAG Appoints RWTH Aachen University Professor Uwe Naumann as Principal Scientist, expanding long standing strategic partnership

Retrieved on: 
Monday, May 9, 2022

OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.

Key Points: 
  • OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.
  • In this role Prof Naumann will help drive the next generation of technical products at NAG through his extensive knowledge of technical and scientific computing and Automatic Differentiation.
  • I am delighted that Professor Naumann will become our first Principal Scientist.
  • Uwe Naumann has been a professor of Computer Science at RWTH Aachen University, Germany, since 2004 and a member of NAG since 2010.

NAG Appoints RWTH Aachen University Professor Uwe Naumann as Principal Scientist, expanding long standing strategic partnership

Retrieved on: 
Monday, May 9, 2022

OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.

Key Points: 
  • OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.
  • In this role Prof Naumann will help drive the next generation of technical products at NAG through his extensive knowledge of technical and scientific computing and Automatic Differentiation.
  • I am delighted that Professor Naumann will become our first Principal Scientist.
  • Uwe Naumann has been a professor of Computer Science at RWTH Aachen University, Germany, since 2004 and a member of NAG since 2010.